Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. When considering the Bio-Techne Corp stock dividend history, we have taken known splits into account, such that the TECH dividend history is presented on a split-adjusted ("apples to apples") basis. Bio-Techne Corp dividend history is presented both in graphical/chart form, and as a TECH dividend history data table along the right-hand column.
|
TECH Stock Dividend HistoryThe TECH dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable TECH historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the TECH dividend history record. Also see the TECH stock dividend history data table along the right-hand column below. |
|
TECH Next Dividend Date » (Projection based upon history) TECH Dividend Growth Rate » Quotes delayed 20 minutes |
Strong Buy (3.71 out of 4) 70th percentile
(ranked higher than approx. 70% of all stocks covered)
Analysts' Target Price: TECH Forecast Based on data provided by Zacks Investment Research via Quandl.com |
Projection: TECH Next Dividend Date Chart: TECH Chart - 5Yr Dividend Yield |